Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303914 · ClinicalTrials.gov registry record
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- 2,310
- Enrollment target
NCT00303914: Completed study, sponsored by Eastern Cooperative Oncology Group.
NCT00303914 is a clinical trial that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 2,310 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00303914 has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- 2,310 participants
- Enrollment target
Study Summary
RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably. PURPOSE: This clinical trial is studying symptoms caused by cancer and cancer therapy in patients with invasive breast, lung, prostate, or colorectal cancer.
Interventions
- PROCEDURE cognitive assessment
- PROCEDURE psychosocial assessment and care
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,310 participants |
| Start Date | 2006-03-14 |
| Est. Completion | 2013-03-04 |
What the finished NCT00303914 record still lists
NCT00303914 is an observational study that tracks outcomes without assigning an intervention. Its 2,310 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which cognitive assessment is the first listed.
NCT00303914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00303914 about?
NCT00303914 is a clinical study titled "Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer". RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably. PURPOSE: This clinical trial is studying symptoms caused by cancer and cancer therapy in...
What is the current status of trial NCT00303914?
This trial is currently completed. The enrollment target is 2,310 participants. The study started on 2006-03-14. Estimated completion is 2013-03-04.
What interventions are being tested in trial NCT00303914?
The interventions under investigation include: cognitive assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00303914?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI